Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Orbimed Advisors Llc | Director, 10%+ Owner | $29.4M | Nov 8, 2022 | ||
Thomas J. Schuetz | PRESIDENT, Director | $9.53M | Feb 8, 2024 | ||
Vered Bisker-Leib | CHIEF EXECUTIVE OFFICER, Director | $4.53M | Feb 8, 2024 | ||
Jonathan Anderman | Sr VP, Gen Counsel & Corp Sec | $1.45K | Aug 13, 2024 | ||
Richard S. Lindahl | Director | Feb 9, 2024 | |||
Susan Kalled | Chief Scientific Officer | Feb 18, 2022 | |||
Brett Kaplan | Director | Feb 18, 2022 | |||
Philip Ferneau | Director | Feb 9, 2024 | |||
David M. Wurzer | Director | Feb 8, 2023 | |||
Stephen P. Squinto | Director | Feb 18, 2022 | |||
Miranda Jayne Toledano | Director | Jun 25, 2021 | |||
Carl L. Gordon | Director, 10%+ Owner | Feb 9, 2024 | |||
Ellen Chiniara | Director | Feb 9, 2024 | |||
James P. Boylan | Director | Mar 8, 2024 | |||
Mary Ann Gray | Director | Feb 9, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|